KI
MRVI icon

Kula Investments’s Maravai LifeSciences MRVI Stock Holding History

Kula Investments’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$536K Buy
38,257
+16,136
+73% +$232K 0.13% 283
2022
Q4 		$317K Buy
+22,121
New +$348K 0.09% 374

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Kula Investments's MRVI Position: Q1 2023 in Review

Kula Investments increased its Maravai LifeSciences (MRVI) stake by 73% in Q1 2023, buying an estimated $232K and bringing the position to 38,257 shares worth $536K. The position accounts for 0.13% of the portfolio, ranked #283.

Kula Investments first reported a position in MRVI in Q4 2022 and has held it in 2 quarters since. 219 funds tracked by Wall St. Rank hold MRVI as of Q1 2023.

  • Kula Investments held 38,257 shares of Maravai LifeSciences worth $536K as of Q1 2023.
  • Kula Investments bought 16,136 Maravai LifeSciences shares in Q1 2023, an estimated $232K.
  • Maravai LifeSciences made up 0.13% of Kula Investments's portfolio in Q1 2023, its #283 holding.
  • Kula Investments first reported a position in Maravai LifeSciences in Q4 2022 and has held it in 2 quarters since.
  • 219 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.